Long-term survivors in severe aplastic anemia: standard mortality rates now comparable to controls?
作者信息
Bacigalupo Andrea
机构信息
Fondazione Policlinico Universitario A.Gemelli IRCCS Roma.
出版信息
Haematologica. 2023 Dec 1;108(12):3199-3200. doi: 10.3324/haematol.2023.283523.
Abstract
摘要
相似文献
1
Long-term survivors in severe aplastic anemia: standard mortality rates now comparable to controls?重型再生障碍性贫血的长期存活者：目前的标准化死亡率与对照组相当吗？
Haematologica. 2023 Dec 1;108(12):3199-3200. doi: 10.3324/haematol.2023.283523.
2
Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.再生障碍性贫血治疗后发生的恶性肿瘤。欧洲骨髓移植-重型再生障碍性贫血工作组。
N Engl J Med. 1993 Oct 14;329(16):1152-7. doi: 10.1056/NEJM199310143291603.
3
Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.获得性再生障碍性贫血的初始治疗：骨髓移植和免疫抑制治疗的结果。西雅图骨髓移植团队。
Ann Intern Med. 1997 Jan 15;126(2):107-15. doi: 10.7326/0003-4819-126-2-199701150-00003.
4
First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy.儿童重型再生障碍性贫血的一线治疗：来自匹配家族供体的骨髓移植与免疫抑制治疗对比。
Haematologica. 2014 Dec;99(12):1784-91. doi: 10.3324/haematol.2014.109355. Epub 2014 Sep 5.
5
6
Acquired aplastic anemia in children.儿童获得性再生障碍性贫血。
Pediatr Clin North Am. 2013 Dec;60(6):1311-36. doi: 10.1016/j.pcl.2013.08.011. Epub 2013 Oct 16.
7
Late clonal diseases of treated aplastic anemia.治疗后再生障碍性贫血的晚期克隆性疾病。
Semin Hematol. 2000 Jan;37(1):91-101.
8
Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia.获得性重型再生障碍性贫血患者的骨髓移植与免疫抑制治疗对比
Int J Hematol. 2016 Aug;104(2):168-74. doi: 10.1007/s12185-016-2037-8. Epub 2016 Jun 8.
9
Immunosuppressive therapy vs. bone marrow transplant for severe aplastic anemia.
J Pediatr Hematol Oncol. 1997 Nov-Dec;19(6):533-4. doi: 10.1097/00043426-199711000-00009.
10
本文引用的文献
1
Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy.造血细胞移植或免疫抑制治疗后至少存活 1 年的重型再生障碍性贫血患者的条件生存和标准化死亡率比。
Haematologica. 2023 Dec 1;108(12):3298-3307. doi: 10.3324/haematol.2023.282781.
2
Aplastic Anemia.再生障碍性贫血
N Engl J Med. 2018 Oct 25;379(17):1643-1656. doi: 10.1056/NEJMra1413485.
3
Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis.严重再生障碍性贫血中 HLA 全相合同胞供者与无关供者移植的当前结局：一项欧洲血液与骨髓移植组（EBMT）分析
Haematologica. 2015 May;100(5):696-702. doi: 10.3324/haematol.2014.115345. Epub 2015 Jan 23.
4
Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.再生障碍性贫血治疗后发生的恶性肿瘤。欧洲骨髓移植-重型再生障碍性贫血工作组。
N Engl J Med. 1993 Oct 14;329(16):1152-7. doi: 10.1056/NEJM199310143291603.
5
Immunosuppression in aplastic anemia--postponing the inevitable?再生障碍性贫血中的免疫抑制——是在拖延不可避免的结局吗？
N Engl J Med. 1991 May 9;324(19):1358-60. doi: 10.1056/NEJM199105093241909.
Zotero 插件